BWAY NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Brainsway Ltd · Healthcare · Medical Devices

Open interactive chart View report data
Latest close 15.23 USD
-4.6% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 8.9% above the Trend Line and sits at 81.8% of its 52-week range. The latest completed week returned -4.6%, after a 0.3% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is expensive relative to peers. Options positioning is bullish with 51/100 conviction, while the latest news-sentiment score is 59/100. Near-term considerations: earnings are due in 10d.

Setup score 61 out of 100
Latest Close 15.23 USD 31 Jul 2026
1W Return -4.6% latest completed week
4W Return 0.3% short-term follow-through
12W Return -11.3% quarterly tape
Trend Breadth 100.0% 52 of 52 weeks active
Volume Ratio 1.2x vs 13-week average
What is working
  • The trend backdrop is active with a 59-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is constructive, supporting the smart-money activity read.
What could go wrong
  • Activity pressure is negative, which weakens the current setup.
  • 5 reversal markers appear in the recent smart-money tape.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -4.6% Latest completed week; four-week move 0.3%. Indicator stack 100/41 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Bullish 51/100 conviction; expected move 10.6%. News sentiment 59/100 61 relevant articles in the latest sentiment read. Event risk 10d Next report is scheduled for 12 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 8.9% above the Trend Line and sits at 81.8% of its 52-week range. The latest completed week returned -4.6%, after a 0.3% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.2x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.8012-week average 0.88

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure4/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.80Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers55 reversal markers

No recent accumulation markers. 5 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 0.3% over four weeks, -11.3% over 12 weeks, and 165.6% over one year. The current trend has remained active for 59 consecutive weeks.

Performance by holding period

1W-4.6%
4W0.3%
12W-11.3%
26W30.3%
52W165.6%
Active trend streak59 weeks
Active weeks in one year52
Trend breadth100.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.65Latest activity-pressure read.
Pressure change34.7%Four-week change in activity pressure.
Leadership23.52Latest relative-leadership reading.
RS change-6.4%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 97% Model confidence 93%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength53/100Blend of value, momentum, and quality. Underlying universe rank 48; rank 1 is best.
Value2/100Relative valuation strength. Underlying universe rank 99; rank 1 is best.
Quality99/100Profitability and accounting quality. Underlying universe rank 2; rank 1 is best.
Momentum98/100Medium-term price momentum. Underlying universe rank 3; rank 1 is best.
Growth95/100Revenue and earnings growth. Underlying universe rank 6; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
72.7x
Price divided by trailing earnings.
Price / sales
11.4x
Market value relative to trailing revenue.
EV / EBITDA
46.9x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
3.1%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
75.5%
Gross profit retained from each unit of revenue.
Operating margin
19.5%
Operating profit retained from revenue.
Free-cash-flow margin
32.3%
Free cash flow generated from revenue.
Return on invested capital
45.7%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
29.4%
Latest one-year revenue growth.
EPS growth
125.1%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
12.9%
Latest one-year free-cash-flow growth.
Piotroski F-score
8/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-4.1x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningBullish

BWAY shows bullish options pressure with a 51/100 conviction score, put-call volume ratio of 0.00, expected move of 10.6%, and Sharemaestro trend signal active.

Conviction51/100
Expected move10.6%
Put/call volume0.00
Pressure100
Speculation9
Volatility71
Trend agreement1
Open options detail
Insider activity-

No recent insider transactions are stored for this company.

News sentiment59/100

Weighted news tone is neutral across 61 relevant articles.

22 positive · 37 neutral · 2 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings10dNext report is scheduled for 12 Aug 2026; event risk rises as the date approaches.
Options expected move10.6%Nearest-chain priced movement where available.
52-week drawdown-12.2%Distance below the 52-week high.
13-week volatility5.9%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher17 of 269 weeks finished lower.
Best week+13.6%Week of 17 Apr.
Worst week-12.6%Week of 5 Jun.
Latest week-4.6%Week of 31 Jul.

Shape of recent returns

Strong gains10
Modest gains7
Flat weeks0
Modest losses3
Sharp losses6
Recent vol5.9%13-week weekly-return volatility.
Base vol6.6%52-week weekly-return volatility.
Up/down split33/19Count of positive and negative weeks in the 52-week window.
Average skew5.6% / -4.0%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape66/100

Trend, activity pressure, participation, and risk combine to a 66/100 tape read.

 Indicator analysis66/100

Latest 12-week confirmation: trend 12/12, activity pressure 4/12, relative leadership 12/12.

Activity pressure 0.80; 5 reversal markers Factors62/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 55; Small Cap Core rank 99 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options47/100

BWAY shows bullish options pressure with a 51/100 conviction score, put-call volume ratio of 0.00, expected move of 10.6%, and Sharemaestro trend signal active.

Bullish · Call-side pressure · Expected move 10.6% Sentiment59/100

Weighted news tone is neutral across 61 relevant articles.

Brainsway (NASDAQ:BWAY) Upgraded at Wall Street Zen Insiders50/100

No recent insider transaction evidence is stored.

 Earnings10d

Next report is scheduled for 12 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202615.23 USD-4.6%13.99 USD6.35 USD-0.6523.52753.8KOn
24 Jul 202615.97 USD1.5%13.80 USD6.26 USD-0.6831.901.1MOn
17 Jul 202615.73 USD4.4%13.60 USD6.17 USD-0.8829.66520.4KOn
10 Jul 202615.06 USD-0.9%13.36 USD6.07 USD-0.9820.55404.3KOn
3 Jul 202615.19 USD4.9%13.14 USD5.99 USD-0.9925.13323.1KOn
26 Jun 202614.48 USD-2.8%12.92 USD5.89 USD-0.9921.60365.7KOn
19 Jun 202614.89 USD1.8%12.73 USD5.81 USD-0.6520.57493.0KOn
12 Jun 202614.63 USD5.3%12.48 USD5.72 USD-0.3023.01435.1KOn
5 Jun 202613.89 USD-12.6%12.25 USD5.63 USD0.2520.88705.0KOn
29 May 202615.89 USD5.2%12.05 USD5.55 USD0.8933.60507.3KOn
22 May 202615.10 USD0.5%11.80 USD5.46 USD1.2732.48637.3KOn
15 May 202615.03 USD-12.5%11.58 USD5.36 USD1.5835.181.3MOn
8 May 202617.17 USD2.0%11.34 USD5.27 USD1.6856.16571.5KOn
1 May 202616.84 USD2.9%11.02 USD5.17 USD1.6764.69586.6KOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.